iifl-logo

Nippon India Pharma Fund Bonus

Nippon India Pharma Fund Bonus

Fund Name

Nippon India Mutual Fund

Scheme Name

Nippon India Pharma Fund Bonus

AMC

Nippon India Mutual Fund

Type

:  Open

Category

Equity - Pharma

Launch Date

10-May-2004

Fund Manager

Sailesh Raj Bhan

Net Assets (Rs. cr)

8352.16

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Nippon India Pharma Fund Bonus - Nav Details

Nav Date

:  09-Jul-2025

NAV [Rs.]

:  519.3169

Buy/Resale Price [Rs.]

0

Sell/Repurchase Price [Rs.]

0

Entry Load %

Nil

Exit Load %

Nippon India Pharma Fund Bonus- NAV Chart

Nippon India Pharma Fund Bonus- Performance(%)

Returns above 1 yr. are annualized

1W
1M
3M
6M
1Y
3Y
5Y
Since INC
Scheme Returns
0.43
1.75
12.46
-0.37
12.56
24.83
22.24
20.57
Category Avg
0.8
2.57
12.29
-1.34
15.18
25.68
22.85
17.85
Category Best
1.81
4.2
17.73
2.31
26.67
30.35
25.82
37.24
Category Worst
0.09
1.58
9.22
-5.5
1.43
21.05
17.57
-2.63

Nippon India Pharma Fund Bonus- Latest Dividends

No Records Found

Nippon India Pharma Fund Bonus- Investment Details

Min. Investment(Rs.)

5000

Increm.Investment(Rs.)

1000

In & Out

In

InName Of The CompanyNo Of Shares
--

Out

InName Of The CompanyNo Of Shares
--

Fund Holdings

Asset Type
Instrument Name
Industry
Net Assets(%)
No of Shares
Mkt Value(Cr.)
Equity & Equity related Investments
EquitySun Pharma.Inds.Pharmaceuticals & Biotechnology12.2362563491,048.37
EquityDivi's Lab.Pharmaceuticals & Biotechnology8.501070031728.63
EquityLupinPharmaceuticals & Biotechnology6.072683991520.15
EquityCiplaPharmaceuticals & Biotechnology5.623200000481.88
EquityApollo HospitalsHealthcare Services5.48648795469.85
EquityDr Reddy's LabsPharmaceuticals & Biotechnology5.183462170444.30
EquityMedplus HealthRetailing3.833627277328.08
EquityGlaxosmi. PharmaPharmaceuticals & Biotechnology3.63919164311.42
EquityNarayana HrudayaHealthcare Services3.551401811304.24
EquityVijaya Diagnost.Healthcare Services3.322886684284.41
EquityGland PharmaPharmaceuticals & Biotechnology3.271529352280.42
EquityAjanta PharmaPharmaceuticals & Biotechnology2.88959323246.93
EquityAbbott IndiaPharmaceuticals & Biotechnology2.8668677244.97
EquityDr Lal PathlabsHealthcare Services2.31709112198.28
EquityZydus Lifesci.Pharmaceuticals & Biotechnology2.312000632198.05
EquitySai LifePharmaceuticals & Biotechnology2.312555745197.68
EquityAurobindo PharmaPharmaceuticals & Biotechnology2.251702630193.21
EquityPfizerPharmaceuticals & Biotechnology2.11318249180.68
EquityMankind PharmaPharmaceuticals & Biotechnology2.05757496175.72
EquityThyrocare Tech.Healthcare Services2.041765838174.90
EquityJ B Chemicals &Pharmaceuticals & Biotechnology1.96999649167.87
EquityAlkem LabPharmaceuticals & Biotechnology1.87323678159.86
EquitySanofi IndiaPharmaceuticals & Biotechnology1.71230272146.71
EquityBioconPharmaceuticals & Biotechnology1.643953457140.62
EquitySanofi ConsumerPharmaceuticals & Biotechnology1.42213659121.70
EquityIpca Labs.Pharmaceuticals & Biotechnology1.27785412109.15
EquitySuraksha Diagno.Healthcare Services1.243269008106.30
EquityTorrent Pharma.Pharmaceuticals & Biotechnology1.21303364103.39
EquityFortis Health.Healthcare Services1.02110388987.70
EquitySyngene Intl.Healthcare Services0.95128049281.81
EquityEmcure PharmaPharmaceuticals & Biotechnology0.7147027260.84
EquityIndoco RemediesPharmaceuticals & Biotechnology0.68183492458.27
EquityAstrazeneca PharPharmaceuticals & Biotechnology0.656256855.73
EquityAkums DrugsPharmaceuticals & Biotechnology0.6594526455.33
EquityOrchid PharmaPharmaceuticals & Biotechnology0.4149272735.19
EquityConcord BiotechPharmaceuticals & Biotechnology0.2411173820.55
Cash & Cash Equivalent
Reverse RepoTREPS-/-0.61052.04
Cash & Cash EquivalentC C I-/-0.0000.33
Net CA & OthersNet CA & Others-/--0.040-6.61

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

MY WEALTH AT RETIREMENT

Calculate the worth of your wealth at retirement

Key information

Fund House:
Nippon India Mutual Fund
Incorporation Date:
24-Feb-1995
Total Assets Managed (Cr.):
6,17,875.24
Trustee/s:
Mr. A N Shanbhag - Associ, Nippon Life India Trustee
Chairman:
NA
CEO / MD:
Mr. Sundeep Sikka
CIO:
NA
President:
NA
Director/s:
Mr. Akira Shibata, Mr. Sushil C. Tripathi, Mr. Kazuhide Toda, Mr. Takayuki Murai
Compliance Officer/s:
Mr. Muneesh Sud
Investor Service Officer/s:
Mr. Milind Nesarikar
Fund Manager/s:
Sailesh Raj Bhan
Auditors:
Haribhakti & Co LLP Chart

OTHER INFORMATION

Registered Office:
4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013.
Contact Nos:
022-68087000/1860260111
Fax:
022-68087097
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.